Impact of Haemophilus influenzae b (Hib) vaccination on meningitis in Central Brazil;Impacto da vacinaçaão contra o Haemophilus influenzae b na redução de meningites, Goiás

Revista de Saude Publica

Volumn 38, Issue 5, 2004, Pages 664-670

  Simões, Luciana Leite Pineli ^a,b   Andrade, Ana Lúcia S S ^b   Laval, Cristina A ^c   Oliveira, Renato M ^b   Silva, Simmone A ^b   Martelli, Celina M T ^b   Alves, Sueli L deA ^d   Almeida, Robmary M ^d   Andrade, João G ^b  

^a Secretaria Estadual de Sau de Hospital de Doenc as Tropicais   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c Secretaria Saude Municipio Goiania   (Brazil)

^d Centro de Assistência Integral à Saúde CAIS Chácara do Governador   (Brazil)

Author keywords

Effectiveness; Haemophilus influenzae type b; Haemophilus vaccines; Meningitis, haemophilus; Prevention control

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HAEMOPHILUS INFLUENZA TYPE B POLYSACCHARIDE VACCINE TETANUS TOXIN CONJUGATE; HAEMOPHILUS INFLUENZA TYPE B POLYSACCHARIDE VACCINE-TETANUS TOXIN CONJUGATE; HAEMOPHILUS VACCINE; TETANUS TOXOID; VACCINE;

ACCURACY; ACUTE DISEASE; AGE DISTRIBUTION; ARTICLE; BACTERIAL MENINGITIS; BRAZIL; CHI SQUARE TEST; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFANT; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; NEISSERIA MENINGITIDIS; PATIENT MONITORING; PRESCHOOL CHILD; RECURRENT INFECTION; RISK REDUCTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; STUDENT T TEST; TREATMENT FAILURE; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNOLOGY;

BRAZIL; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INCIDENCE; INFANT; MALE; MENINGITIS, HAEMOPHILUS; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 11344258388     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-89102004000500008     Document Type: Article

References (18)

1. Andrade ALSS, Brandileone MC, DiFabio JL, Oliveira RM, Silva AS, Baiocchi SS, Martelli CMT. Haemophilus influenzae resistance in Latin America: systematic review of surveillance data. Microb Drug Resistance 2001;7:403-11.
2. Bokermann S, Zanella RC, Lemos APS, Andrade ALSS, Brandileone MCC. Evaluation of serotyping methodology of invasive and nasopharyngeal isolates of Haemophilus influenzae (Hi) in the ongoing surveillance in Brazil. J Clin Microbiol 2003;41:5546-50.
3. Centers for Diseases Control. Proposed changes in format for presentation of notifiable disease report data. MMWR 1989; 38:805-9.
4. Heath PT, McVernon J. The UK Hib vaccine experience. Arch Dis Child 2002;86:396-9.
5. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS, Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet 2003;362:65-71.
6. Landgraf IM, Vieira MF. Biotypes and serotypes of Haemophilus influenzae from patients with meningitis in the city of São Paulo, Brazil. J Clin Microbiol 1993;31:743-5.
7. Lipsitch M. Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae. Emerg Infect Dis 1999;5:336-45.
8. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-7.
9. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13:302-17.
10. Pushparajah K, Ramnarayan P, Maniyar A, Paget R, Britto J. Continued threat of Haemophilus influenzae type B disease in the UK. Lancet 2003;361:90.
11. Ramsay M, Slack M, Kaczmarski E. Surveillance of Haemophilus influenzae infection. Surveillance data for assessing impact of vaccination are valid. BMJ 2001;322:613-4.
12. Ribeiro GS, Reis JN, Cordeiro SM, Lima JB, Gouveia EL, Petersen M et al. Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil. J Infect Dis 2003;187:109-16.
13. Takemura NS, Andrade SM. Meningite por Haemophilus influenzae tipo b em cidades do estado do Paraná, Brasil. J Pediatria 2001;77:387-92.
14. Weiss DP, Coplan P, Guess H. Epidemiology of bacterial meningitis among children in Brazil, 1997-1998. Rev Saúde Pública 2001;35:249-55.
15. World Health Organization. Generic protocol for population-based surveillance of Haemophilus influenzae type B. Geneva; 1996. (WHO/VRD/GEN/95.05).
16. World Health Organization. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae and Haemophilus influenzae. Geneva; 1999. (WHO/CDS/CSR/EDC/99.7). Available from: http://www.who.int/ emcdocuments/meningitis/does/who cdscsredc997.pdf. [2004 Jun 10].
17. World Health Organization. Countries having introduced Hib vaccine. Geneva; 2001. Available from: http://www.who.int/vaccines-surveillance/graphics/htmls/hibmap.htm [2004 Jun 10].
18. World Health Organization. Haemophilus influenzae tipo b Hib meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatalily rates. Geneva; 2002. Available from: http://www.who.int/vaccines-documents/DocsPDF02/www696.pdf [2004 Jun 10].